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Abstract. In a fetal autopsy series, we have explored the
occurrence of renal tubular dysgenesis in twins. Renal
tubular dysgenesis was found exclusively among those
monozygotic twins with evidence of twin transfusion syn-
drome, particularly in those donor twins with oligohy-
dramnios and growth restriction. We infer that hypotension
in the donor twin of the twin transfusion syndrome pair is
responsible for the failure of proximal convoluted tubule
differentiation, and the disturbance of renal function is
manifested as oligohydramnios prenatally, and either oli-
guria or tubular dysfunction postnatally.
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Introduction
Renal tubular dysgenesis (RTD) is characterized by di-
minished to absent differentiation of proximal convoluted
tubules (PCTs) [1], which are shorter and straighter than
normal [2]. There may also be increased cortical and
medullary mesenchyme (and later fibrosis) and dilation of
Bowman's spaces and tubules. The histological changes in
the kidney strongly suggest ischemic injury, with the added
component of deficient tubular differentiation.
In addition to its occurrence as a hereditary syndrome,
RTD is a characteristic finding in angiotensin-converting
enzyme (ACE) inhibitor fetopathy [3]. We hypothesized
that the failure of PCT differentiation in RTD is a result of
renal hypoperfusion, due to fetal hypotension, or altered
hemodynamics within the kidney [4, 5]. To look for sup-
porting evidence, we examined the kidneys of midgestation
twins, a number of whom were affected by the twin
transfusion syndrome.
Materials and methods
The study comprised autopsy data from 128 twins with no major
malformations and minimal to no maceration. Included were 26 dizy-
gous fetuses (DZ, 13 pairs, different sex), 56 fetuses of unknown
zygosity (UZ, 28 pairs, like sex and no significant discrepancy in size
but no placental information), and 46 monozygous fetuses (MZ,
21 pairs and 4 individual donor twins). Postmenstrual ages ranged
from 16.1 to 28.6 weeks.
Z-scores (observed ± expected/standard deviation) of body, brain,
heart, and kidney weights were calculated from normative data
collected at the Universities of Michigan and South Alabama [6].
Because the variance of measurements about the mean expands with
fetal growth, the Z-score method permits standardization across
different fetal ages [6]. A sample of normal, or typical for age,
singleton fetuses in the same age range as the twin sample was used
as controls for comparing visceral weights. Larger and smaller twins
were compared with the controls separately using two-tailed t-tests
(Table 1). Larger and smaller twins were compared with each other
using paired t-tests (Table 2).
Microscopic sections of kidneys were examined, without knowl-
edge of the clinical characteristics of the fetus, for the presence or
absence of PCT differentiation (Fig. 1).
Additionally, number of glomeruli in a ´400 microscopic field was
determined, just inward from the zone of nephrogenesis, using the
mean of 15 fields from each fetus. This count is a reflection of the
increased density of glomeruli that results from the absence of space-
occupying, normally developed PCTs.
Results
Among the DZ and UZ twins, no significant deviation from
the expected mean was found for heart or kidney weights,
and there were no significant differences between the larger
and smaller twins (Fig. 2). Brain weights of the DZ and UZ
twins were comparable to controls, but there were small but
statistically significant differences when larger twins were
compared with smaller twins by paired t-test (Table 2).
Among the MZ twins, there was significant sparing of brain
growth in the smaller twin and a much heavier heart in the
larger twin [7] (Fig. 2). In the smaller twins, the heart and
kidneys were markedly light for brain weight standards, but
less so for body weight standards.
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Heart and brain weight discrepancies were used as a
marker for twin transfusion syndrome: a large heart in the
recipient twin and a heavy brain for body weight in the
donor twin. There were 17 sets of MZ twins that had such
evidence of twin transfusion syndrome, to which we added
the 4 individual donor twins. There were 4 sets of MZ twins
that were unaffected by the twin transfusion syndrome and
had visceral weight profiles similar to the DZ twins.
Comparing donor twins with (10) and without (11) PCT
differentiation, those without PCT differentiation showed
somewhat more growth restriction of brain, heart, and
kidney (Fig. 2), and their mean glomerular counts were
higher (9.2 vs. 7.1) (Fig. 3). Among the DZ and UZ twins,
all had differentiated PCTs, and their mean glomerular
counts (6.6± 6.9) were very similar (Fig. 3).
Among the MZ twins, oligohydramnios was cited in the
clinical information of 6 donor twins. Their mean glo-
merular count was 8.3; 3 had no PCT differentiation and
their mean glomerular count was 9.6. In an additional 9 MZ
twin sets, polyhydramnios was reported without distin-
guishing whether one or both twins were affected. From the
presence of compressional deformation of the face, hands,
and feet, oligohydramnios was inferred for 6 individual
twins (all donors) among these 9 sets. None of these 6 twins
had PCT differentiation and their mean glomerular count
was 9.6. The other 3 had PCT differentiation and their
mean glomerular count was 7.1.
Discussion
RTD is a characteristic feature of ACE inhibitor fetopathy.
RTD has been fully described in four cases of ACE in-
hibitor fetopathy [3, 8]. It was probably the lesion in the
case reported by Knott et al. [9], and it has been observed in
a number of unreported cases. The renin angiotensin system
becomes crucially important under conditions of low renal
perfusion pressure [10, 11]. Under these conditions, which
pertain to the fetus, angiotensin II-mediated efferent arter-
iolar resistance is essential to the maintenance of glomer-
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Fig. 1a, b. Renal cortex in twin transfusion syn-
drome at 22.1 postmenstrual weeks.
a Recipient twin: glomeruli intermingled with nor-
mal proximal convoluted tubules (PCTs).
b Donor twin: glomeruli appear more numerous due
to the absence of differentiated PCTs between them.
In both a and b immature glomeruli are to the right,
progressing to mature glomeruli on the left (hema-
toxylin and eosin, ´155)
ular filtration and production of urine [12, 13]. ACE in-
hibitors reduce glomerular filtration pressure by dilating the
glomerular efferent arterioles. How this might affect
differentiation of PCTs is not certain. While type 1
angiotensin II receptors mediate all the known effects of
angiotensin related to the renin angiotensin system, type 2
receptors appear to be involved in the development of the
kidney [14, 15]. Suppression of their function by ACE in-
hibition may affect tubular differentiation.
RTD has also been reported as a congenital autosomal
recessive disease, with oligohydramniotic deformation and
pulmonary hypoplasia [1, 2, 16, 17]. Bernstein and Barajas
[18] demonstrated increased renin in preglomerular arter-
ioles, glomerular hila, and mesangial areas in the hereditary
form of RTD. The renin accumulation suggested faulty
feedback control of renin secretion in this variety of RTD.
They hypothesized that the increased renin accumulation
reflected strong local vasoconstriction resulting in reduced
glomerular perfusion, which would link it to the RTD seen
in ACE inhibitor fetopathy.
Possible support for the renal ischemia hypothesis
comes from Landing et al. [19] who noted that RTD has
been seen as a unilateral lesion in young infants with renal
artery stenosis due to arteritis or medial arterial calcinosis,
and that it resembles the renal tubular atrophy of a variety
of end-stage kidney diseases, such as glomerulonephritis,
tubulointerstitial kidney disease, obstructive uropathy, and
pyelonephritis, graft rejection of transplanted kidneys, and
the renal parenchymal changes associated with protracted
dialysis therapy. Landing et al. [19] reported that labelled
lectins that differentially mark proximal convoluted, distal
convoluted, connecting, and collecting tubules showed no
distinctive differences in the staining patterns of the hy-
poplastic renal tubules in RTD compared with kidneys af-
fected by postnatal renal artery obstruction or various types
of end-stage renal disease. These findings suggest that the
renal tubular changes in the conditions cited result from
renal ischemia.
However, the issue of mechanism is far from settled and
may be more complicated than renal ischemia leading
directly to RTD. In the fetal sheep, when renal oxygen
delivery was limited by a prolonged reduction in hemato-
crit, sodium and water excretion increased and resulted in
an increase in amniotic fluid volume [20], in contrast to the
oligohydramnios seen in ACE inhibitor fetopathy. Thus, it
would appear that, in the case of ACE inhibitor exposure,
the initiating event for RTD may be a derangement of both
fetal physiology and function of the renin-angiotensin
system by the drug, which may secondarily interfere with
differentiation of PCTs.
When examining the specificity of this set of histo-
pathological findings for ACE inhibitor exposure, Martin et
al. [4] studied the fetuses of women who were chronically
hypertensive. Three of these mothers used antihypertensive
agents throughout pregnancy, including 1 who used an
ACE inhibitor. The tubular morphology of the kidneys was
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Table 1. Comparison by two-tailed t-test of Z-scores of control fetuses with larger and smaller twins
Larger twin Smaller twin
t df P t df P









































































































































DZ, Dizygous; UZ, unknown zygosity; MZ, monozygous; TTS, twin transfusion syndrome; PCT, proximal convoluted tubule differentiation;
BRNBDY, brain weight for body weight standards; HRTBDY and HRTBRN, heart weight for body and brain weight standards respectively;
KIDBDY and KIDBRN, kidney weight for body and brain weight standards respectively
compared with the renal tubules of 20 normal controls,
13 fetuses with various multiple malformation syndromes,
and 6 cases of the twin transfusion syndrome. Features of
RTD were identified in the ACE inhibitor-exposed case, 1
methyldopa-exposed case, and 2 cases of twin transfusion
syndrome [4].
Twinning occurs in approximately 1 in 90 births. Of
these about 30% are monozygous, the vast majority of
which are monochorionic [21]. Among monochorionic
twins, 85% ±100% have intraplacental vascular anasto-
moses, approximately 30% of whom will have evidence of
circulatory imbalance known as the twin transfusion syn-
drome [22].
Hawkins et al. [23] noted that three of five donor twins
they examined had a decreased percentage of PCTs. Genest
and Lage [24] reported 6 examples of absent PCTs among
500 perinatal autopsies; 3 were twins with the twin trans-
fusion syndrome. We surmised that the circulatory im-
balance found in the twin transfusion syndrome is likely to
reduce renal perfusion and glomerular perfusion pressure in
the donor twin. If this were true, and by analogy with the
mechanism in ACE inhibitor fetopathy, RTD could be ex-
pected to result. We found failure of PCT differentiation in
11 of 21 donor twins but in none of 17 recipient twins, 26
DZ twins, or 56 twins of unknown zygosity without evi-
dence of twin transfusion syndrome.
RTD is found in ACE inhibitor fetopathy, hereditary
RTD, and donor twins of the twin transfusion syndrome.
These three lines of evidence suggest that alteration of
glomerular perfusion can result in impaired differentiation























































































































































































































































Fig. 2. Z-scores of brain, body, heart, and
kidney weight by twin type or characteristic.
The bars represent the observed
mean + 1 SD, with the normal range
(mean + 1 SD) indicated by the shaded
area. DZ, Dizygous; UZ, unknown zygosity;
MZ, monozygous; L, larger twin; S, smaller
twin; R, recipient twin; D, donor twin
This study indicates that the prenatal marker for the MZ
twin likely to have RTD is the combination of growth re-
striction and oligohydramnios. In such circumstances,
pulmonary hypoplasia is a common finding. However,
these findings have implications for more than the prenatal
and immediate neonatal prognosis of twins, for significant
postnatal renal morbidity may occur in the affected donor
twin. Infants with twin transfusion syndrome can have a
classic picture of acute tubular necrosis with full recovery,
marked decrease in renal perfusion leading to cortical ne-
crosis and renal failure, or permanent tubular dysfunction
with polyuria, most compatible with tubular dysgenesis.
For many, the problems these infants experience are not
due just to acute tubular necrosis acquired in the neonatal
period, but are a consequence of a developmental defect
originating in midgestation. The challenge will be to see if
a means to prevent the occurrence of RTD in MZ twins can
be devised.
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Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit
and growth hormone binding protein in nephrotic children
Dieter Haffner, Burkhard ToÈnshoff, Werner F. Blum, Marc Vickers, Thomas Siebler, Michael J. Cronin, Robert C. Baxter, and Otto Mehls
We hypothesized that the increased glomerular permeability to serum
proteins in the nephrotic syndrome might lead to alterations of the
somatotropic hormone axis, thereby contributing to growth failure and
catabolism in the nephrotic state. The insulin-like growth factors
(IGF)-I and -II and the IGF binding proteins (IGFBP)-1, -2 and -3 were
analyzed in serum and urine of 21 children with the nephrotic syn-
drome and normal glomerular filtration rate. Mean age-related serum
IGF-I levels by RIA (±0.53+0.34 SD) were slightly, but significantly
(P 50.05) decreased compared with the reference population, whereas
mean age-related serum IGF-II levels (0.68+0.21 SD) were slightly,
but significantly (P 50.005) increased. The urinary excretion rate of
both peptides was enhanced fivefold. By RIA, mean age-related serum
IGFBP-1 (2.05+0.19 SD) and, even more pronounced, IGFBP-2
(5.97+0.65 SD) were clearly elevated despite a 12-fold and 2-fold
increase of the respective urinary excretion rate. There was a tight and
specific correlation between age-related serum IGFBP-2 levels and the
degree of the nephrotic syndrome, as estimated by serum albumin
levels (r = 0.78, P 50.0001). Serum immunoreactive IGFBP-3 levels
were also elevated (1.79+0.33 SD) in nephrotic serum, due to an
increase of low-molecular weight IGFBP-3 fragments. By FPLC
analysis, there was a decrease of the 150 kDa IGFBP ternary complex
in nephrotic serum, which in the presence of normal concentrations of
the acid-labile subunit by RIA appears to be due to a reduction of intact
IGFBP-3. Serum levels of the high-affinity GH binding protein that
presumably reflects GH receptor status in tissues were normal. In
summary, total serum IGFs in children with the nephrotic syndrome
are normal, but the binding of IGFs to IGFBPs in the circulation is
altered with a shift from the 150 kDa IGFBP complex to an excess of
low molecular weight IGFBPs. Because increased unsaturated high-
affinity IGFBPs in nephrotic serum have the ability to inhibit IGF
action on target tissues by competing with the type 1 IGF receptor for
IGF binding, this alteration is likely to contribute to growth failure and
tissue catabolism in the nephrotic state.
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